Tyvaso Dosing and Titration Evaluation: TyTRATE Registry

March 20, 2015 updated by: United Therapeutics

A Patient Registry to Observe the Real-World Dosing and Titration of Tyvaso®

This prospective, observational, multi-center, patient registry will follow patients who are newly initiated on Tyvaso for the treatment of Pulmonary Arterial Hypertension (PAH). Once enrolled, the patients' dose and titration will be followed for the first 6 months of treatment with Tyvaso.

A call-center will contact the patients directly at weeks 1, 2, 3, 4, 8, 12, 16, 20, and 24 to review their dose and titration schedule. In addition to patient-reported dosing data, some patient demographic information, will be collected by the investigative site at Baseline.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

98

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Guaynabo, Puerto Rico, 00968
        • CardioPulmonary Research Center
    • California
      • La Jolla, California, United States, 92037
        • The Regents of the University of California
      • Los Angeles, California, United States, 90095
        • UCLA Medical Center
      • Pasadena, California, United States, 91101
        • Southern California Permanente
      • San Luis Obispo, California, United States, 93401
        • Central Coast Chest Consultants
      • Stockton, California, United States, 95210
        • Pacific Sleep Disorders Center
    • Connecticut
      • West Hartford, Connecticut, United States, 06107
        • Prime Healthcare, PC
    • Florida
      • Brandon, Florida, United States, 33511
        • Bay Area Cardiology Associates, PA
      • Celebration, Florida, United States, 32747
        • Florida Lung & Sleep Specialist
      • Jacksonville, Florida, United States, 32216
      • Miramar Beach, Florida, United States, 32550
        • Sacred Heart Medical Group
      • Pensacola, Florida, United States, 32501
        • Cardiology Consultants
      • Pensacola, Florida, United States, 32504
        • Pensacola Lung Group
      • Pensacola, Florida, United States, 32504
        • Sacred Heart Medical Group
      • Tampa, Florida, United States, 33607
        • Pediatrix Cardiology Associates
    • Georgia
      • Augusta, Georgia, United States, 30909
        • Doctors Hospital of Augusta
      • Cumming, Georgia, United States, 30041
        • On Site Clinical Solutions
      • Duluth, Georgia, United States, 30096
        • Duluth Biomedical Research
      • Lawrenceville, Georgia, United States, 30046
        • Gwinnett Consultants in Cardiology
      • Roswell, Georgia, United States, 30076
        • Atlanta Cardiology Consultants
    • Hawaii
      • Aiea, Hawaii, United States, 97601
        • Queens Medical Center - Honolulu
    • Illinois
      • Chicago, Illinois, United States, 60611
        • Ann & Robert H. Lurie Children's Hospital of Chicago
      • Gurnee, Illinois, United States, 60031
        • Dor Heart and Vascular Clinic
      • Maywood, Illinois, United States, 60153
        • Loyola University of Chicago
      • Oakbrook, Illinois, United States, 60523
        • Advocate Medical Group
      • Peoria, Illinois, United States, 61636
        • Methodist Medical Center of Illinois
    • Indiana
      • Indianapolis, Indiana, United States, 46202
        • Clarian Health Methodist Hospital
    • Maryland
      • Hyattsville, Maryland, United States, 20782
        • MedStar Health Institute
      • Pikesville, Maryland, United States, 21117
        • Pulmonary and Care Associates of Baltimore
    • Michigan
      • Milwaukee, Michigan, United States, 53212
        • Madison Medical Affiliates
    • Mississippi
      • Pascagoula, Mississippi, United States, 39581
        • Singing River Health System
    • New Jersey
      • Union, New Jersey, United States, 07083
        • AZ Perfection Clinical
    • New Mexico
      • Albuquerque, New Mexico, United States, 87106
        • Presbyterian Heart Group
    • New York
      • Bayside, New York, United States, 11361
        • Heart and Lung Associates, PC
      • Brooklyn, New York, United States, 11215
        • New York Methodist Hospital
    • North Carolina
      • Asheville, North Carolina, United States, 28803
        • Asheville Cardiology Associates
    • North Dakota
      • Fargo, North Dakota, United States, 58122
        • Sanford Heart Hospital
    • Ohio
      • Cincinnati, Ohio, United States, 45229
        • Children's Hospital Medical Center
      • Cleveland, Ohio, United States, 44195
        • The Cleveland Clinic Foundation
      • Dayton, Ohio, United States, 45459
        • Midwest Pulmonary & Sleep Research
      • Middleburg Heights, Ohio, United States, 44130
        • Southwest General Health Center
    • Oklahoma
      • Oklahoma City, Oklahoma, United States, 73112
        • Integris Baptist Medical Center, Inc
    • Pennsylvania
      • Wynnewood, Pennsylvania, United States, 19096
        • The Lankenau Institute for Medical Research
      • York, Pennsylvania, United States, 17405
        • Wellspan Health
    • Tennessee
      • Columbia, Tennessee, United States, 20910
        • Maury Regional Medical Center
    • Texas
      • San Antonio, Texas, United States, 78229
        • Pulmonary Consultants of San Antonio, PA
    • Virginia
      • Charlottesville, Virginia, United States, 22903
        • The Rector and Visitors of the University of Virginia
      • Roanoke, Virginia, United States, 24014
        • Carilion Medical Center
    • Washington
      • Spokane, Washington, United States, 99204
        • Pulmonary & Sleep Research
    • Wisconsin
      • Madison, Wisconsin, United States, 53705
        • University of Wisconsin School of Medicine and Public Health
      • Milwaukee, Wisconsin, United States, 53226
        • Medical College of Wisconsin
      • Milwaukee, Wisconsin, United States, 53226
        • The Medical College of Wisconsin, Inc.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients newly initiating on Tyvaso therapy for the treatment of PAH

Description

Inclusion Criteria:

  • Are newly prescribed Tyvaso for the treatment of PAH and plan to initiate therapy
  • Are willing and able to be contacted by the patient call center.

Exclusion Criteria:

  • Have previously received Tyvaso.
  • Are currently enrolled in an interventional (non-FDA approved) PH clinical trial.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Observe dose changes of Tyvaso over time
Time Frame: 6 Months
6 Months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2013

Primary Completion (ACTUAL)

December 1, 2014

Study Completion (ACTUAL)

December 1, 2014

Study Registration Dates

First Submitted

February 12, 2013

First Submitted That Met QC Criteria

February 22, 2013

First Posted (ESTIMATE)

February 26, 2013

Study Record Updates

Last Update Posted (ESTIMATE)

March 24, 2015

Last Update Submitted That Met QC Criteria

March 20, 2015

Last Verified

May 1, 2014

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • RIN-PH-404

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.